| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.28 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |